Ramucirumab as a second-line treatment for hepatocellular carcinoma: reaching out further to patients with elevated alpha-fetoprotein

Shranjeno v:
Bibliografske podrobnosti
izdano v:Hepatobiliary Surg Nutr
Main Authors: Giannini, Edoardo G., Trevisani, Franco
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2019
Teme:
Editorial
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6791995/
https://ncbi.nlm.nih.gov/pubmed/31673543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2019.04.19
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki